CRP and coronary artery disorder: While each of these molecules presents a compelling case as a prospective biomarker for CAD and some hold promise as viable therapeutic targets, it is imperative to acknowledge that none has yet attained the comprehensive support spanning basic, clinical, and translational investigations akin to that enjoyed by CRP.